Moderna Therape…
ProfileJobs (84)

Moderna Therapeutics

Suggest Edit
    • Healthbiotechclinical researchdrug developmentpharma

    Moderna is pioneering messenger RNA therapeutics™, an entirely new in vivo drug modality that produces human proteins or antibodies inside patient cells, which are in turn active intracellularly or secreted. This breakthrough platform addresses currently undruggable targets, and offers a superior alternative to existing drug modalities for a wide range of disease conditions.


    Market valuation(2018-02-02)
    $7.5 B
    Total Funding
    $1.7 B
    Type
    Private
    HQ
    Cambridge, US
    Size (employees)
    628 (est)+4%
    Website
    modernatx.com
    Moderna Therapeutics is headquartered in Cambridge, US
    Report incorrect company information

    Key People/Management at Moderna Therapeutics

    Stephane Bancel

    Stephane Bancel

    CEO
    Lorence Kim

    Lorence Kim

    CFO
    Stephen Hoge

    Stephen Hoge

    President
    Noubar Afeyan

    Noubar Afeyan

    Chairman & Co-Founder
    Tal Zaks

    Tal Zaks

    Chief Medical Officer
    Steve Harbin

    Steve Harbin

    SVP of Human Resources & Clinical Supply Operations
    Show more

    Moderna Therapeutics Office Locations

    Moderna Therapeutics has offices in Huntington, Chicago, Norwood, Cambridge and in 1 other location
    Cambridge, US (HQ)
    320 Bent St
    Cambridge, US
    NE47 500 Technology Square
    Cambridge, US
    200 Technology Square
    Huddinge, SE
    Hälsovägen 7-9
    Show all (7)
    Report incorrect company information

    Moderna Therapeutics Financials and Metrics

    Summary Metrics

    Total Funding

    		$1.7 b

    Latest funding size

    		$500 m

    Time since last funding

    		3 months ago

    Investors

    		BB Biotech Ventures, Invus, Abu Dhabi Investment Authority, Sequoia Capital China, AstraZeneca, Fidelity Management and Research Company, Julius Baer Group, RA Capital Management, Biomedical Advanced Research and Development Authority (BARDA), Alexandria Venture Investments, Viking Global Investors, Alexion Pharmaceuticals, Flagship Ventures, Wellington Management, EDBI, Pictet Private Equity Investors S.A., ArrowMark Partners, DARPA, Bill & Melinda Gates Foundation
    Moderna Therapeutics's latest funding round in February 2018 was reported to be $500 m. In total, Moderna Therapeutics has raised $1.7 b. Moderna Therapeutics's latest valuation is reported to be $7.5 b.

    Moderna Therapeutics Financials

    USD

    Revenue (Jun, 2016)

    		36 m

    Market valuation

    		7.5 b
    USDJun, 2016

    Revenue

    		36 m
    show all
    USDY, 2016

    Revenue/Employee

    		99.4 k
    Show all financial metrics

    Moderna Therapeutics Operating Metrics

    Moderna Therapeutics's Patent Applications was reported to be 250 in May, 2017.
    Y, 2015May, 2017

    Drugs in Development

    		92

    Patent Applications

    		250
    Show all operating metrics
    Report incorrect company information

    Competitors

    Sarepta Therapeutics
    Health - Public
    Regulus Therapeutics
    Health - Public
    CureVac
    Health - Private
    Evelo Biosciences
    Health - Private
    Compare competitors

    Moderna Therapeutics News and Updates

    February 02, 2018

    Moderna Therapeutics racks up $500 mln

    Cambridge, Massachusetts-based Moderna Therapeutics, a developer of messenger RNA therapeutics and vaccines, has raised $500 million in funding. The investors include a subsidiary of the Abu Dhabi Investment Authority, EDBI, Sequoia Capital China, Fidelity Management & Research Company, Pictet, …
    Report incorrect company information
    Download PDF